ResearcherOchsner Medical CenterActive in the last 2 years
John S. Bolton
Matched on OpenAlex author ID A5113719826. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 32
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers
Papers 6
- Liquid biopsy for early detection of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41591-026-04625-x↗
- Author Correction: Liquid biopsy for early detection of pancreatic ductal adenocarcinoma Co-author DOI 10.1038/s41591-026-04775-y↗
- A Circulating Panel of circRNA Biomarkers for the Noninvasive and Early Detection of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2023.09.050↗
- An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study. Co-author DOI 10.1053/j.gastro.2022.06.090↗
- Multiagent neoadjuvant chemotherapy and tumor response are associated with improved survival in pancreatic cancer. Co-author DOI 10.1016/j.hpb.2018.08.013↗
- Surgical treatment of pancreatic cancer. First author PMID 21667805↗
Closest collaborators
The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Eunsung Jun · 4 shared papers, 2022–2026 · strength 0.70
- Paper Liquid biopsy for early detection of pancreatic ductal adenocarcinoma. DOI 10.1038/s41591-026-04625-x↗
- Paper Author Correction: Liquid biopsy for early detection of pancreatic ductal adenocarcinoma DOI 10.1038/s41591-026-04775-y↗
- Paper A Circulating Panel of circRNA Biomarkers for the Noninvasive and Early Detection of Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2023.09.050↗
- Erkut Hasan Borazanci · 4 shared papers, 2022–2026 · strength 0.70
- Paper Liquid biopsy for early detection of pancreatic ductal adenocarcinoma. DOI 10.1038/s41591-026-04625-x↗
- Paper Author Correction: Liquid biopsy for early detection of pancreatic ductal adenocarcinoma DOI 10.1038/s41591-026-04775-y↗
- Paper A Circulating Panel of circRNA Biomarkers for the Noninvasive and Early Detection of Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2023.09.050↗
- Ajay Goel · 4 shared papers, 2022–2026 · strength 0.70
- Paper Liquid biopsy for early detection of pancreatic ductal adenocarcinoma. DOI 10.1038/s41591-026-04625-x↗
- Paper Author Correction: Liquid biopsy for early detection of pancreatic ductal adenocarcinoma DOI 10.1038/s41591-026-04775-y↗
- Paper A Circulating Panel of circRNA Biomarkers for the Noninvasive and Early Detection of Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2023.09.050↗
- Daniel D. Von Hoff · 4 shared papers, 2022–2026 · strength 0.70
- Paper Liquid biopsy for early detection of pancreatic ductal adenocarcinoma. DOI 10.1038/s41591-026-04625-x↗
- Paper Author Correction: Liquid biopsy for early detection of pancreatic ductal adenocarcinoma DOI 10.1038/s41591-026-04775-y↗
- Paper A Circulating Panel of circRNA Biomarkers for the Noninvasive and Early Detection of Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2023.09.050↗
- Song Cheol Kim · 3 shared papers, 2024–2026 · strength 0.59
- Paper Liquid biopsy for early detection of pancreatic ductal adenocarcinoma. DOI 10.1038/s41591-026-04625-x↗
- Paper Author Correction: Liquid biopsy for early detection of pancreatic ductal adenocarcinoma DOI 10.1038/s41591-026-04775-y↗
- Paper A Circulating Panel of circRNA Biomarkers for the Noninvasive and Early Detection of Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2023.09.050↗
- Derek Cridebring · 3 shared papers, 2022–2026 · strength 0.50
- Paper Liquid biopsy for early detection of pancreatic ductal adenocarcinoma. DOI 10.1038/s41591-026-04625-x↗
- Paper Author Correction: Liquid biopsy for early detection of pancreatic ductal adenocarcinoma DOI 10.1038/s41591-026-04775-y↗
- Paper An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarc… DOI 10.1053/j.gastro.2022.06.090↗
- Carlos Roberto Becerra · 3 shared papers, 2022–2026 · strength 0.50
- Paper Liquid biopsy for early detection of pancreatic ductal adenocarcinoma. DOI 10.1038/s41591-026-04625-x↗
- Paper Author Correction: Liquid biopsy for early detection of pancreatic ductal adenocarcinoma DOI 10.1038/s41591-026-04775-y↗
- Paper An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarc… DOI 10.1053/j.gastro.2022.06.090↗
- Haiyong Han · 3 shared papers, 2022–2026 · strength 0.50
- Paper Liquid biopsy for early detection of pancreatic ductal adenocarcinoma. DOI 10.1038/s41591-026-04625-x↗
- Paper Author Correction: Liquid biopsy for early detection of pancreatic ductal adenocarcinoma DOI 10.1038/s41591-026-04775-y↗
- Paper An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarc… DOI 10.1053/j.gastro.2022.06.090↗
- Caiming Xu · 2 shared papers, 2026 · strength 0.39
- Mitsuro Kanda · 2 shared papers, 2026 · strength 0.39
- Laleh Golkar Melstrom · 2 shared papers, 2026 · strength 0.39
- Giulia Martina Cavestro · 2 shared papers, 2026 · strength 0.39
- Douglas B. Evans · 2 shared papers, 2026 · strength 0.39
- David L. Bartlett · 2 shared papers, 2026 · strength 0.39
- Vincent M. Chung · 2 shared papers, 2026 · strength 0.39
- Alessandro Mannucci · 2 shared papers, 2026 · strength 0.39
- Joon Oh Park · 2 shared papers, 2026 · strength 0.39
- Dong Shang · 2 shared papers, 2026 · strength 0.39
- Mustafa Raoof · 2 shared papers, 2026 · strength 0.39
- Guixin Zhang · 2 shared papers, 2024–2026 · strength 0.39
- Caiming Xu · 1 shared paper, 2024 · strength 0.20
- Dong Shang · 1 shared paper, 2024 · strength 0.20
- Akinobu Taketomi · 1 shared paper, 2024 · strength 0.20
- William Charles Conway · 2 shared papers, 2011–2019 · strength 0.17
- Nathan M. Bolton · 1 shared paper, 2019 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.